These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
308 related items for PubMed ID: 14975390
1. Prognostic significance of morphological subtypes in canine malignant lymphomas during chemotherapy. Ponce F, Magnol JP, Ledieu D, Marchal T, Turinelli V, Chalvet-Monfray K, Fournel-Fleury C. Vet J; 2004 Mar; 167(2):158-66. PubMed ID: 14975390 [Abstract] [Full Text] [Related]
2. A morphological study of 608 cases of canine malignant lymphoma in France with a focus on comparative similarities between canine and human lymphoma morphology. Ponce F, Marchal T, Magnol JP, Turinelli V, Ledieu D, Bonnefont C, Pastor M, Delignette ML, Fournel-Fleury C. Vet Pathol; 2010 May; 47(3):414-33. PubMed ID: 20472804 [Abstract] [Full Text] [Related]
3. Doxorubicin alone or in combination with asparaginase, followed by cyclophosphamide, vincristine, and prednisone for treatment of multicentric lymphoma in dogs: 121 cases (1987-1995). Valerius KD, Ogilvie GK, Mallinckrodt CH, Getzy DM. J Am Vet Med Assoc; 1997 Feb 15; 210(4):512-6. PubMed ID: 9040837 [Abstract] [Full Text] [Related]
4. Canine lymphomas: association of classification type, disease stage, tumor subtype, mitotic rate, and treatment with survival. Valli VE, Kass PH, San Myint M, Scott F. Vet Pathol; 2013 Sep 15; 50(5):738-48. PubMed ID: 23444036 [Abstract] [Full Text] [Related]
5. Aberrant phenotypes and quantitative antigen expression in different subtypes of canine lymphoma by flow cytometry. Gelain ME, Mazzilli M, Riondato F, Marconato L, Comazzi S. Vet Immunol Immunopathol; 2008 Feb 15; 121(3-4):179-88. PubMed ID: 17981339 [Abstract] [Full Text] [Related]
6. Results of chemotherapy for cats with alimentary malignant lymphoma: 21 cases (1993-1997). Zwahlen CH, Lucroy MD, Kraegel SA, Madewell BR. J Am Vet Med Assoc; 1998 Oct 15; 213(8):1144-9. PubMed ID: 9787382 [Abstract] [Full Text] [Related]
7. Immunophenotypic classification of canine malignant lymphoma on formalin-mixed paraffin wax-embedded tissue by means of CD3 and CD79a cell markers. Milner RJ, Pearson J, Nesbit JW, Close P. Onderstepoort J Vet Res; 1996 Dec 15; 63(4):309-13. PubMed ID: 9173362 [Abstract] [Full Text] [Related]
8. Outcome and toxicity associated with a dose-intensified, maintenance-free CHOP-based chemotherapy protocol in canine lymphoma: 130 cases. Sorenmo K, Overley B, Krick E, Ferrara T, LaBlanc A, Shofer F. Vet Comp Oncol; 2010 Sep 15; 8(3):196-208. PubMed ID: 20691027 [Abstract] [Full Text] [Related]
9. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules. Wilkerson MJ, Dolce K, Koopman T, Shuman W, Chun R, Garrett L, Barber L, Avery A. Vet Immunol Immunopathol; 2005 Jul 15; 106(3-4):179-96. PubMed ID: 15963817 [Abstract] [Full Text] [Related]
10. Histologic classification as an indication of therapeutic response in malignant lymphoma of dogs. Gray KN, Raulston GL, Gleiser CA, Jardine JH. J Am Vet Med Assoc; 1984 Apr 01; 184(7):814-7. PubMed ID: 6725115 [Abstract] [Full Text] [Related]
11. The cytology, histology and prevalence of cell types in canine lymphoma classified according to the National Cancer Institute Working Formulation. Carter RF, Valli VE, Lumsden JH. Can J Vet Res; 1986 Apr 01; 50(2):154-64. PubMed ID: 3756669 [Abstract] [Full Text] [Related]
12. Histologic classification and immunophenotyping of canine non-Hodgkin's lymphomas: unexpected high frequency of T cell lymphomas with B cell morphology. Teske E, Wisman P, Moore PF, van Heerde P. Exp Hematol; 1994 Nov 01; 22(12):1179-87. PubMed ID: 7925781 [Abstract] [Full Text] [Related]
13. Retrospective study of 82 cases of canine lymphoma in Austria based on the Working Formulation and immunophenotyping. Guija de Arespacochaga A, Schwendenwein I, Weissenböck H. J Comp Pathol; 2007 Nov 01; 136(2-3):186-92. PubMed ID: 17416237 [Abstract] [Full Text] [Related]
14. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage]. Zou GR, Zhang YJ, Xie FY, Zheng W, Li HX, Xia YF, Lin TY, Lu TX. Ai Zheng; 2006 Dec 01; 25(12):1543-9. PubMed ID: 17166383 [Abstract] [Full Text] [Related]
15. Cytosine arabinoside in addition to VCAA-based protocols for the treatment of canine lymphoma with bone marrow involvement: does it make the difference? Marconato L, Bonfanti U, Stefanello D, Lorenzo MR, Romanelli G, Comazzi S, Zini E. Vet Comp Oncol; 2008 Jun 01; 6(2):80-9. PubMed ID: 19178667 [Abstract] [Full Text] [Related]
16. Efficacy of a continuous, multiagent chemotherapeutic protocol versus a short-term single-agent protocol in dogs with lymphoma. Simon D, Moreno SN, Hirschberger J, Moritz A, Kohn B, Neumann S, Jurina K, Scharvogel S, Schwedes C, Reinacher M, Beyerbach M, Nolte I. J Am Vet Med Assoc; 2008 Mar 15; 232(6):879-85. PubMed ID: 18341445 [Abstract] [Full Text] [Related]
17. Prognostic factors for treated canine malignant lymphoma. Kiupel M, Teske E, Bostock D. Vet Pathol; 1999 Jul 15; 36(4):292-300. PubMed ID: 10421095 [Abstract] [Full Text] [Related]
18. Canine T-cell lymphomas: a morphological, immunological, and clinical study of 46 new cases. Fournel-Fleury C, Ponce F, Felman P, Blavier A, Bonnefont C, Chabanne L, Marchal T, Cadore JL, Goy-Thollot I, Ledieu D, Ghernati I, Magnol JP. Vet Pathol; 2002 Jan 15; 39(1):92-109. PubMed ID: 12102223 [Abstract] [Full Text] [Related]
19. Outcome and prognostic factors in ocular adnexal lymphoma. Nola M, Lukenda A, Bollmann M, Kalauz M, Petrovecki M, Bollmann R. Croat Med J; 2004 Jun 15; 45(3):328-32. PubMed ID: 15185428 [Abstract] [Full Text] [Related]
20. Use of fine needle aspirates and flow cytometry for the diagnosis, classification, and immunophenotyping of canine lymphomas. Sözmen M, Tasca S, Carli E, De Lorenzi D, Furlanello T, Caldin M. J Vet Diagn Invest; 2005 Jul 15; 17(4):323-30. PubMed ID: 16130989 [Abstract] [Full Text] [Related] Page: [Next] [New Search]